Injection end point monitoring system and method
The integration of a processor, magnetometer, and accelerometer in an injection monitoring system allows precise detection of the injection endpoint, addressing the challenge of non-rotating dose setting wheels in pen-type systems, ensuring reliable dose administration feedback.
Patent Information
- Application Number
- CN202280095395.0
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2022-04-28
- Publication Date
- 2024-12-06
AI Technical Summary
Existing injection monitoring systems struggle to accurately determine the endpoint of an injection, particularly for pen-type injection systems where the dose setting wheel does not rotate during injection.
An injection endpoint monitoring system integrated with a processor, magnetometer, and accelerometer, which processes data from a rotating magnetic field generator and translational movement to determine the injection endpoint.
Accurately detects the injection endpoint, providing reliable monitoring and enabling real-time feedback on administered doses, even for systems without a rotating dose setting wheel.
Smart Images

Figure CN119095636A_ABST
Abstract
Description
[0001] The present invention generally relates to systems and methods for determining an injection endpoint.
[0002] In general, being able to determine when an injection endpoint is reached is highly desirable for a variety of reasons, particularly for the safety of the user of the injection system or the patient administering the injection. Various methods and systems are generally known in the art, for example in infusion systems. One area of more particular interest is being able to determine or monitor an injection endpoint event in a handheld injection device such as a pen-type injection system.
[0003] As used herein, the terms "pen injection system" and "injection pen system" are used interchangeably to refer to commonly used handheld pen injection systems, which are well known per se and commercially available for use in treating or managing a wide variety of different medical indications. These systems are also typically designed for self-injection of medication by the user who is required to treat or manage a given medical indication. This is the case, for example, with insulin, which is supplied in various forms for use in treating diabetes, such as pen injection systems commercially available under various brand names, such as Novo Nordisk, Inc. Brand sales, Eli Lilly and Company Lantus These are just three of the most well-known. Other medications are also used with these medical devices, for example, to manage other medical conditions such as hormone deficiency or hormone overproduction related conditions, as well as to respond to potentially life-threatening situations and be able to immediately administer the medication needed for emergency use, such as anaphylactic shock treatment, anticoagulants, opioid receptor agonists and antagonists, etc. For patients suffering from or susceptible to such conditions, it has become common to carry these devices with them.
[0004] For example, particularly with respect to injection pen systems, one of the challenges is to provide an easy-to-use, reliable and relatively safe monitoring and measuring system that can be adapted to the various different variants of such commercially available pen injection systems, of which there are many. The electronic dose measuring device is adapted and configured to be removably attached to the injection pen system thereto, typically equipped with a dose setting wheel and an injection activator located at the proximal end. The dose setting wheel rotates about the central longitudinal axis of the pen injection system to allow the user to set a dose of the injected drug. During the dose setting or dose "setting" step, the dose setting wheel is typically rotatable in clockwise and counterclockwise directions, these directions typically corresponding to an increase in the selected dose to be administered and a decrease in the selected dose, or vice versa, respectively, depending on the manufacturer. The injection activator is typically represented by a button, typically located at the proximal end of the dose setting wheel, and in most injection pens at the proximal end of the injection pen system. After the dose has been set or "set" (as the term is known in the art), when the user of the injection system subsequently depresses the injection activator in the distal direction, a piston connected to the plunger is driven so as to expel the drug from the chamber in the body of the injection pen through the needle, which is inserted by the user into a suitable injection site, such as the skin, fatty tissue or muscle, depending on the type of drug to be administered. The dose setting wheel is sometimes (but not necessarily) also connected to the injection drive mechanism, so that, depending on the manufacturer and model of the injection pen, it can also rotate as the injection of the drug proceeds. The function of such an injection system itself is well known in the art.
[0005] The monitoring module is intended to be mounted on a pen-type injection system, wherein the dose setting wheel can be configured to rotate during the ejection / injection phase of operation, or conversely, not to rotate during the ejection / injection phase of operation of the pen-type injection system. The injection pen does not have a dose setting wheel that rotates during injection, and the Lantus and The dose setting wheel of the injection pen rotates during injection.
[0006] Injection monitoring and dose measurement are known per se when related to injection pen systems and enable users of such pen injection systems and healthcare professionals involved in the treatment and follow-up of such patients to more closely monitor their own injection regimens and, in many cases, the doses actually administered, in order to obtain better healthcare outcomes. These developments have been accompanied by an associated increase in the use of software and portable communication devices (such as tablets or smartphones) that have been programmed to receive information from and interact with the monitoring and measurement systems in order to provide information to the user or healthcare professional in real time or periodically via an appropriate communication unit included in the monitoring system. The injection monitoring module is adapted and configured to be detachably attached to the proximal end of such an injection pen system. The expressions "detachably attached", "removably attached", "detachably mounted" or "removably mounted" as may be used in this specification are to be understood as referring to the possibility of attaching, or installing, and subsequently removing, or disassembling, or detaching the injection monitoring module, for example, in the case of transferring the injection monitoring module to another pen injection system, or for example if the injection monitoring module is damaged during use and needs to be replaced. Such attachment and subsequent detachability may be achieved by providing a coupling device on the injection monitoring module which engages in a releasable manner with the proximal end of the pen injection system, for example by frictional or elastic engagement, or by other releasable fastening means such as a clip, a band, a thread and a corresponding fastening ring or the like, which engage with the dose setting wheel or the injection actuator and / or even the body of the injection pen system.
[0007] The applicant has previously filed a number of patent applications related to detachably attached electronic injection monitoring modules for such handheld injection pen systems, which have been published, such as WO2020 / 217076, WO2020 / 217094 and WO2021 / 260404A1. Therefore, the detachably attached injection monitoring modules described in these patent applications can generally be described as being configured and adapted to be detachably attached to the proximal end of an injection pen having an injection activation button included at the proximal end of the injection pen to activate the injection. More specifically, the injection monitoring module generally includes the following structure:
[0008] a distal cylindrical body having a longitudinal bore and a central longitudinal axis, the distal cylindrical body being adapted and configured to be coaxially mounted and rotationally engaged with a proximal dose selection wheel located proximal to and distal to an injection activation button of the pen-type injection system, the distal cylindrical body further comprising at least one magnetic field generating element located at or adjacent the proximal end of the distal cylindrical body; and
[0009] A proximal electronic injection monitoring body, including an electronic injection monitoring system, is configured to be mounted within a bore of a distal cylindrical body, and wherein the electronic injection monitoring body is selectively axially movable along a central longitudinal axis and freely rotatable about the central longitudinal axis.
[0010] Thus, this structure combines an outer body at the distal end, which engages and rotates with a dose setting wheel of a pen injection system during dose setting and / or optionally during dose injection, depending on the specific function of the injection pen, and an inner proximal body containing an electronic dose measurement circuit, wherein the inner body is generally free to rotate about a central longitudinal axis, but selectively axially movable along said central longitudinal axis within the bore of the distal cylindrical body. Depending on the function of the injection pen, the system of the electronic injection monitoring module body is configured to record changes in the magnetic field when the magnetic field generating element rotates about the central longitudinal axis during dose setting and / or dose injection, and also to record changes in the magnetic moment along the central longitudinal axis using the selective axial movement along the central longitudinal axis to also help determine other operating conditions, such as starting from the injection of an injectable substance such as a drug by the pen injector. In these cases, the selective axial movement refers to the operation of the injection pen, for example, indirectly pressing an actuator button by a corresponding button element provided at the proximal end of the proximal electronic injection monitoring module body, to achieve injection of a substance contained in a cartridge or chamber included in the pen injection system, for example, containing a suitable drug or other injectable substance. Similarly, once actuation of the pen injector button ceases, for example due to a user releasing finger pressure on the proximal button of the electronic dose measuring body, the button is selectively moved in the proximal direction, typically by recoil in the pen injection system or by a return spring provided in the electronic dose measuring body, thereby allowing a return to a reset position of the dose measuring device to be detected or recorded by the electronic circuit.
[0011] In all of the above, the concepts of proximal and distal generally refer to relative positions with respect to any one of an injection monitoring system, an injection monitoring module and a pen injection system, where "proximal" relates to a point, position or direction generally in the direction of a holder of an injection monitoring system, an injection monitoring module or a pen injection system, and "distal" relates to a point, position or direction generally in the direction away from the holder of an injection monitoring system, an injection monitoring module or a pen injection system, for example towards a target site for injection, whether it is another part of the user's body, the body of a different person or animal, or simply a target site for injection of a substance contained within a pen injection system.
[0012] As described above, the applicant has previously filed and disclosed an application for determining when a dose has been set or when an injection has been started, using an electronic injection monitoring module as described above, which integrates an electronic injection monitoring system, which has, on the one hand, at least one rotatable magnet configured to rotate around a central longitudinal axis of the injection monitoring system, and, on the other hand, has at least one magnetometer that can be axially translated along the central longitudinal axis.
[0013] Nonetheless, there are still many significant challenges in determining and / or monitoring the injection endpoint, particularly for injection pen systems where the dose setting wheel does not rotate during injection.
[0014] Thus, one aspect of the present invention is a system and method for monitoring and / or determining an injection endpoint, of a type suitable and configured for integration into an injection endpoint monitoring module as described above.
[0015] Therefore, another aspect of the present invention is an injection endpoint monitoring system adapted and configured to be integrated into an injection monitoring module mounted to the proximal end of a pen-type injection system, the pen-type injection system including a proximal activation button, the injection endpoint monitoring system comprising:
[0016] a processor, a magnetometer, and an accelerometer, wherein the magnetometer and the accelerometer are electrically connected to the processor, the processor being configured to receive data and / or information from the magnetometer and / or the accelerometer;
[0017] a magnetic field generator configured to provide a magnetic field detected by the magnetometer, wherein the magnetic field generator is configured to rotate about a first axis of the system;
[0018] wherein the magnetometer is located on the first axis of the system and is configured to move translationally along the first axis of the system;
[0019] Where the processor is configured to process:
[0020] data and / or information received from a magnetometer as a result of the rotation of the magnetic field generator about said first axis of the system, and determining from said data and / or information whether a dose setting operation has been performed;
[0021] data and / or information received from the accelerometer as a result of translational movement of the accelerometer along a first axis of the system; and
[0022] Therein, the processor is configured to process data and / or information synchronously received from the magnetometer and the accelerometer to determine an endpoint of an injection operation of the pen-type injection system.
[0023] As mentioned above, the term data and / or information refers to signals, values, arrays, etc., which are represented in a form or structure known or understood by the processor for subsequent processing. Therefore, the data and / or information representation can be in a form known per se, which is transmitted from the magnetometer and accelerometer to the processor and received by the processor. For example, the data can be in the form of electrical signals, optoelectronic signals or optical signals, and the processor integrates corresponding circuits and / or programming logic and / or instructions, which are configured to process the signals.
[0024] Similarly, as is generally understood, a magnetic field generator generates a three-dimensional magnetic field, and the corresponding magnetic field generated by the magnetic field generator is usually read or detected by a magnetometer in a known manner along x, y and z axes, each of which is orthogonal to each other. As described above, data and / or information from the magnetometer readings are transmitted to a processor.
[0025] Magnetic field generators are known per se, for example, classical magnets, electromagnets and hybrid material magnets. Such magnets are typically made of magnetizable materials that have magnetic or paramagnetic properties, either naturally or when an electric current or other excitation flow passes through or affects the material to generate or induce a magnetic field in the material. Suitable materials can be appropriately selected from:
[0026] - ferrite magnets, in particular sintered ferrite magnets, for example, comprising a crystalline compound of iron, oxygen and strontium;
[0027] - Composite materials consisting of a thermoplastic matrix and isotropic NdFeB powder;
[0028] - composite materials consisting of a thermoplastic matrix and strontium-based hard ferrite powder, the magnets produced thereby may contain either isotropic, i.e. non-oriented, or anisotropic, i.e. oriented, ferrite particles;
[0029] - Composite materials made of a thermosetting plastic matrix and isotropic NdFeB powder;
[0030] - magnetic elastomers, for example, made by mixing large amounts of charged strontium ferrite powder with synthetic rubber or PVC and then extruding it into the desired shape or calendering it into thin sheets;
[0031] -Flexible calendered composites, usually having the appearance of brown sheets, which are more or less flexible depending on their thickness and composition. These composites are never as elastic as rubber and tend to have a Shore hardness in the range of about 40 to about 70 Shore ANSI. Such composites are usually formed from a synthetic elastomer filled with strontium ferrite particles. The resulting magnets can be either anisotropic or isotropic, with the thin sheet variety usually having magnetic particle alignment due to calendering;
[0032] - a laminated composite material, typically comprising a flexible composite material as described above, laminated together with a soft iron plate;
[0033] - Neodymium Iron Boron magnets;
[0034] -Steel made of Alnico and magnetized;
[0035] - Alloy of samarium and cobalt.
[0036] In the above list of magnetic field generators suitable for the present invention, those selected from the group consisting of neodymium-iron-boron permanent magnets, magnetic elastomers, composite materials consisting of a thermoplastic matrix and strontium-based hard ferrite powder, and composite materials made of a thermosetting plastic matrix and isotropic neodymium iron boron powder are preferred. Such magnets are known for their ability to be autonomous in relatively small sizes while maintaining relatively high magnetic field strengths.
[0037] According to another aspect, the first axis is a z-axis. The z-axis advantageously coincides with and is coextensive with a central longitudinal axis of the injection monitoring system and / or the injection monitoring module.
[0038] According to another aspect, the processor is configured to process data it receives from the magnetometer relating to a selective selection of an x-axis, a y-axis, or a z-axis, or a combination of one or more of said axes, positioned orthogonally relative to one another.
[0039] According to another aspect, the processor is configured to determine that a dose has been set if:
[0040] Data and / or information is received from the magnetometer, the data and / or information indicating that a resultant magnetic field strength increases to be greater than a baseline magnetic field strength when the system is at rest and less than a maximum resultant magnetic field strength, the increase resulting from the magnetic field generator rotating about the first axis.
[0041] According to another advantageous aspect, the resultant magnetic field strength is determined from readings taken from the x-axis and the y-axis. As described above, the processor can advantageously be configured accordingly to selectively process data from the x-axis and the y-axis of the magnetometer, for example, to determine the resultant magnetic field strength.
[0042] The processor is integrated, programmed or configured to execute programmed logic and / or instructions, for example stored in the memory, to compare a baseline composite magnetic field strength of the system when at rest or a series of values representing the baseline composite magnetic field strength with actual readings received from the magnetometer when using the injection monitoring system, and calculate whether the composite magnetic field strength determined by the read magnetic field strength is less than a maximum composite magnetic field strength.
[0043] The baseline synthetic magnetic field strength can be determined empirically, for example by measuring the magnetic field strength generated in situ by any provided magnetic field generator in a monitoring module mounted on the injection system; or it can be pre-calculated using a mathematical model based on the size and nominal strength of the magnetic field generator, and the stationary position of the magnetic field generator relative to the magnetometer, taking into account any background magnetic fields, such as the Earth's magnetic field (EMF), or any required error or offset corrections.
[0044] Similarly, the maximum resultant magnetic field strength may be determined empirically, for example by measuring the magnetic field strength produced in situ by any provided magnetic field generator in a monitoring module mounted on the injection system, and then operating the injection system to simulate or replicate the start of an injection, or may be pre-calculated using a mathematical model based on the size and nominal strength of the magnetic field generator and the position of the magnetic field generator as the magnetometer moves along the z-axis relative to the magnetic field generator, and also taking into account any background magnetic field, such as the earth's magnetic field (EMF), or any required error or offset correction. The maximum resultant magnetic field strength is produced when the magnetometer moves or translates along the z-axis, from a stationary position on the z-axis to a position on the z-axis where the injection is started, when the injection start is in effect, and when the injection is in progress.
[0045] The baseline or minimum composite magnetic field strength and the maximum composite magnetic field strength may be stored in the system, such as in a memory, for access by the processor when needed.
[0046] The processor compares the predetermined baseline composite magnetic field strength and the maximum composite magnetic field strength with the actual strength read from the magnetometer and received by the processor to determine whether a dose has been set. This comparison can also be optionally used to determine whether the magnetic field generator is rotated about the z-axis for other reasons (e.g., accidentally).
[0047] The dose setting step produces a characteristic sequence of synthetic magnetic field strengths which can be appropriately recognised by the system's processor and the processor is programmed accordingly, or an executable instruction set, e.g. stored in a memory, is provided, such that such a sequence can be recognised and regarded as a dose setting step.
[0048] To the extent that the processor receives data and / or information from the accelerometer, such data and / or information may indicate a variety of conditions based on the measured values, such as a baseline acceleration of the system that does not exceed a minimum value, which may be determined empirically or mathematically for each pen-type injection system and monitoring module, such as by hands-on testing or modeling, in a manner similar to how baseline composite magnetic field strength and maximum composite magnetic field strength are determined. The acceleration values may be suitably stored in a memory that is accessed by the processor when needed.
[0049] The processor is suitably integrated, programmed or configured to execute programmed logic and / or instructions to compare a baseline value or series of values of acceleration over time with an actual value or series of values read from the accelerometer over time and make a corresponding determination of an operating state with respect to the comparison.
[0050] Typically, if the acceleration data does not indicate an increase in acceleration values that exceeds a predetermined baseline acceleration value or range of values, the injection monitoring system has not moved in the proximal or distal direction along the central longitudinal axis coincident with the z-axis, and the processor will record such a condition in the injection monitoring system. Alternatively, if the processor determines from the comparison that the acceleration value or range of acceleration values does not exceed the predetermined baseline acceleration value, and the processor determines that an increase in the magnetic field reading corresponding to a dose setting operation has occurred, the processor is configured to record that a dose setting operation has occurred.
[0051] When the injection monitoring system is integrated into a corresponding injection monitoring module, the magnetic field generator may be suitably provided by a pair of single dipole magnets located in corresponding recesses provided in an outer cylindrical body of the injection monitoring module. The magnets may suitably be rod-shaped or cylindrical dipole magnets, one located relative to the other facing in opposite polarity directions, for example NS aligned with SN, the magnets being positioned to lie flat along their own longitudinal axes, passing through a horizontal plane bisecting and orthogonal to the central longitudinal axis, each magnet being located on opposite sides of said central longitudinal axis, for example one rotated 180° around said central longitudinal axis relative to the other.
[0052] Similarly, the electronic circuit is suitably located within the electronic injection monitoring module body, which is located in the central longitudinal axis and can translate along the central longitudinal axis, and is at least partially located at the proximal end of the outer cylindrical body. The electronic circuit includes a processor, a magnetometer and an accelerometer, for example, on a suitably configured printed circuit board, and an autonomous or semi-autonomous power source, such as a lithium-ion battery or a rechargeable battery. For example, the processor can be integrated into a microcontroller, which integrates a system clock, which can, for example, be configured to function based on the operating frequency of the processor and / or microcontroller.
[0053] According to another aspect, the processor is configured to determine that an injection endpoint has been reached when:
[0054] receiving data and / or information from a magnetometer, the data and / or information being indicative of a maximum combined magnetic field strength; and
[0055] Data and / or information is received from an accelerometer, the data and / or information indicating an absence of acceleration along the z-axis for a predetermined duration.
[0056] In relation to the above, the term "absence of acceleration" means that the accelerometer does not detect, or the processor is configured to ignore, any acceleration value below a predetermined threshold, which value may be different from the minimum acceleration value, for example, and may be pre-programmed into the system, as well as determined by experience or mathematical modeling. Similarly, the expression "predetermined duration" as used herein refers to a duration typically comprised between about 0.1 seconds and about 2 seconds.
[0057] According to another aspect, the processor is configured to sample data and / or information received from the magnetometer and / or accelerometer at a frequency between about 20 Hz and about 400 Hz in a known manner common to the signal processing art.
[0058] According to another aspect, the processor is configured to simultaneously and synchronously analyze the magnetogram curve of the data and / or information received from the magnetometer and the acceleration curve of the data and / or information received from the accelerometer to determine any predefined operating state of the injection process, such as a reset position, in which the injection monitoring system has returned to the initial pre-dose setting and / or pre-injection position, in which the magnetometer and the accelerometer have been moved in the proximal direction to the pre-dose setting and / or pre-injection position. Or, for example, the processor can be configured to determine whether a partial injection has been performed, for example, in the case of the start of an injection operation, the chamber or cartridge containing the substance to be injected is exhausted or used up during the injection process, so that only a portion of the set dose of the required and injectable substance can be injected. In this case, the processor is configured to store the intermediate received values provided by the magnetometer and the accelerometer in order to calculate only a portion of the set dose that has been administered. This partially administered dose value can then be uploaded to, for example, a smartphone application via a wireless connection integrated into the monitoring system, and the application is configured to provide visual feedback to the user of the monitoring system about the administration and treatment observation data. Additionally, the storage of partial injection data enables, when the injection monitoring module is removed from a depleted pen injection system and installed on a new pen injection system with a newly filled injectable substance chamber or cartridge, the smartphone application to notify the user of the amount of the remaining dose programmed on the new pen injection system in order to complete the injection of the required total dose.
[0059] According to another aspect, there is provided an injection monitoring module comprising an injection monitoring system as generally described herein, wherein:
[0060] a magnetic field generator located on a first cylindrical body having a central longitudinal hole and a central longitudinal axis, the first cylindrical body being configured to rotate about the central longitudinal axis, and
[0061] The processor, magnetometer, and accelerometer are located on the second body, and the second body is configured to translate within the central longitudinal bore of the first cylindrical body from a first proximal injection position to a second distal injection position.
[0062] According to another aspect, there is provided a method for determining an injection endpoint, comprising:
[0063] Installing an injection monitoring module to the proximal end of the injection pen system, the injection monitoring module including the described injection endpoint monitoring system, the injection pen system including a proximal activation button;
[0064] Adjust the dose on the pen system;
[0065] a proximal activation button for activating the pen system;
[0066] The processor of the injection endpoint monitoring system is configured to process data and / or information synchronously received from the magnetometer and the accelerometer of the injection endpoint monitoring system to determine an endpoint of an injection operation of the injection pen injection system.
[0067] Other aspects of the invention will become apparent from the invention or the description herein with reference to the accompanying drawings, which are provided as illustrative examples, in which:
[0068] Figure 1A and 1B is a schematic cross-sectional view of an injection monitoring module integrated with an endpoint injection monitoring system according to the present invention;
[0069] Figure 2 is a schematic perspective view of a portion of detail of an electronic injection monitoring system according to the present invention;
[0070] Figure 3A is a schematic diagram of the injection curve, showing the magnetic field and acceleration values changing with time;
[0071] Figure 3B is with Figure 3A Graph of the synchronized injection monitoring system showing the phased movement. DETAILED DESCRIPTION
[0072] Now go to Figure 1A and 1B , the injection monitoring module (1) includes an injection monitoring system (2) according to the present invention, and the structure of the injection monitoring module (1) is similar to the structure described in the applicant's previously disclosed PCT application WO2020217076A1 or WO2020217094A1. In short, the injection monitoring module (1) is configured and suitable for being detachably attached to the proximal end of a syringe pen (not shown), which has an injection start button included at the proximal end of the syringe pen to start the injection. The injection monitoring module (1) generally includes a distal cylindrical body (3), the distal cylindrical body (3) having a longitudinal hole (4) and a central longitudinal axis (5), and for the purpose of the present invention, the central longitudinal axis (5) is also the z-axis of the injection monitoring system, such as Figure 2 and Figure 3B As shown. The distal cylindrical body (3) is adapted and configured to be coaxially mounted and rotationally engaged with a proximal dose selector wheel located near and distal to an injection start button of a pen-type injection system (not shown), and also includes at least one magnetic field generator (6A, 6B) located at or adjacent to the proximal end (7) of the distal cylindrical body (3). The injection monitoring module (1) also includes a proximal electronic injection monitoring body (8), which includes an electronic injection monitoring system (2), and the electronic injection monitoring body (8) is configured to be mounted in the hole (4) of the distal cylindrical body (3). The electronic injection monitoring body (8) can selectively move axially along the central longitudinal axis (5, z) and freely rotate around the central longitudinal axis (5, z). Figure 1A and 1B More specifically, the relative positions of the proximal injection monitoring body (8) and the distal cylindrical body (3) with respect to each other during operation of the injection monitoring module are shown. Figure 1A The position when setting or adjusting the dose is shown, wherein the distal cylindrical body (3) is rotated about the central longitudinal axis (5, z), as indicated by the corresponding arrow (9), and the injection monitoring body (8) is located at the maximum proximal distance from the distal cylindrical body (3). Figure 1B The injection step ( Figure 1B ), wherein the proximal injection monitoring body (8) is translated in the distal direction according to the corresponding arrow (10), and the pen-type injection system activation button is activated by the surface engagement contact between the distal facing surface (11) of the injection monitoring body (8) and the pen-type injection system activation button to achieve injection. Similarly, the injection monitoring body (8) is configured to translate in the proximal direction once the injection is completed, and remove the engagement surface contact between the distal facing surface (11) and the injection button.
[0073] Figure 2 Some details of an electronic injection monitoring system (2) are shown, including a printed circuit board (12), the printed circuit board including a processor or microcontroller (13), the microcontroller including a processor, a magnetometer (14), an accelerometer (15) and an autonomous power source holder (16), the autonomous power source holder configured to hold and retain an autonomous power source, such as a lithium-ion battery. Figure 2A virtual overlay of a central longitudinal axis (5, z) passing through the center of the magnetometer (14) is also shown. A microcontroller (13) comprising a processor of the electronic injection monitoring system (2) is configured to receive data and / or information, such as magnetic field strength and / or magnetic field vector, from the magnetometer (14) during dose setting when a magnetic field generator (6A, 6B), such as a pair of dipole magnets, rotates about the central longitudinal axis (5, z). As the electronic injection monitoring system (2) translates along the central longitudinal axis (5, z), the magnetic field strength and / or magnetic field vector also change because the magnetometer (14) moves in a distal direction through the magnetic field generated by the magnetic field generator (5A, 5B) during injection and moves back through the magnetic field after the injection is completed when the injection monitoring system body (8) translates in a proximal direction back to an initial resting position or zero position. The accelerometer (15) captures the acceleration of the electronic injection monitoring body (8), and the processor of the microcontroller (13) is configured to receive data and / or information structures from the accelerometer (15) when the injection monitoring system body (8) moves or translates along the central longitudinal axis (5, z).
[0074] Figure 3A A profile trajectory or a magnetogram showing the time variation of the synthetic magnetometer intensity along the central longitudinal axis (5, z) at different stages is shown, as well as the operating status of the injection monitoring system and the injection monitoring module (1) integrated with such an injection monitoring system (2), and an accelerometer curve trajectory or graph or accelerometer reading within the same time span is shown below the magnetogram. Figure 3B The corresponding schematic positions and / or movements of the injection monitoring system at each stage of the injection operation are shown. Figure 3B Also shown are respective perpendicularly oriented axes x and y relative to the central longitudinal axis (5, z) which are associated with the resultant magnetic field strength generated by the magnetic field generators (6A, 6B).
[0075] Figure 3A The initial part of the diagram in shows that the system is at rest. The measured synthetic magnetometer (14) strength and the measured accelerometer (15) values received by the processor are both at their respective minimum values, i.e., their respective baseline values. Figure 3A It can be seen that the accelerometer value is basically equal to 0m.s -2 , while the baseline magnetometer strength of the exemplary monitoring module and monitoring system is about 1650 microtesla. During dose setting, i.e., when the magnetic field generator (5A, 6B), as shown by the N / S representing the magnetic poles of the magnetic field generator, rotates about the central longitudinal axis (5, z), as shown by Figure 3BAs shown by the corresponding arrows in the figure, the magnetometer reading increases above the baseline level, but remains below the maximum value. In the example shown in Figure 3, the dose setting step lasts a total of approximately 4 to 6 seconds, but the time may vary depending on the monitoring module and the injection pen system in which the monitoring module is installed. During this dose setting or dose adjustment phase, Figure 3A It can be seen that the accelerometer value remains at the accelerometer baseline value.
[0076] During the injection step, Figure 3B As shown, the injection monitoring system moves in the distal direction along the central longitudinal axis (5, z) at the beginning of the injection. Figure 3B The corresponding arrows in Figure 3A The graph shows a sudden increase in the resultant magnetic field intensity and the accelerometer values. The resultant magnetic field intensity reaches a maximum value, and the accelerometer values can be positive or negative. As the injection progresses, these values continue to increase. However, from Figure 3A As can be seen in the figure, the composite magnetic field strength reported by the magnetometer (14) to the injection monitoring system processor and the acceleration value reported by the accelerometer (15) to the injection monitoring system processor show different curves when the system reaches the injection end point. This is manifested as a substantial absence or no acceleration, while the reading of the magnetometer (14) remains substantially at the maximum value during the same time period. Finally, when the user of the injection system releases the injection system's start button, the injection monitoring system moves or translates in the proximal direction along the z-axis, i.e. Figure 3B This causes the magnetometer reading to drop back down to the magnetometer baseline, while the accelerometer reading indicates a brief spike.
Claims
1. An injection endpoint monitoring system adapted and configured to be integrated into an injection monitoring module, the injection monitoring module being mounted to the proximal end of a pen-type injection system, the pen-type injection system comprising a proximal activation button, the injection endpoint monitoring system comprising: a processor, a magnetometer, and an accelerometer, wherein the magnetometer and accelerometer are electrically connected to the processor, the processor being configured to receive data and / or information from the magnetometer and / or accelerometer; a magnetic field generator configured to provide a magnetic field detected by the magnetometer, wherein the magnetic field generator is configured to rotate about a first axis of the system; wherein the magnetometer is located on the first axis of the system and is configured to move translationally along the first axis of the system; Wherein, the processor is configured to process: data and / or information received from the magnetometer as a result of the magnetic field generator rotating about a first axis of the system, and determining from the data and / or information whether a dose setting operation has been performed; data and / or information received from the accelerometer as a result of translational movement of the accelerometer along a first axis of the system; and Wherein, the processor is configured to process data and / or information synchronously received from the magnetometer and accelerometer to determine an endpoint of an injection operation of the pen-type injection system.
2. The injection endpoint monitoring system according to claim 1, wherein: The first axis is the z-axis.
3. The injection endpoint monitoring system according to claim 1, wherein: The processor is configured to process data it receives from the magnetometer relating to a selective selection of an x-axis, a y-axis or a z-axis positioned orthogonally relative to one another, or a combination of one or more of said orthogonally positioned axes.
4. The injection endpoint monitoring system according to claim 1, wherein: The processor is configured to determine that a dose has been set if: Data and / or information is received from the magnetometer, the data and / or information indicating that a composite magnetic field strength increases to be greater than a composite baseline magnetic field strength of the system when at rest and less than a maximum composite magnetic field strength, the increase being caused by the magnetic field generator rotating about the first axis.
5. The injection endpoint monitoring system according to claim 4, wherein: The resultant magnetic field strength is determined from the readings taken from the x-axis and y-axis.
6. The injection endpoint monitoring system according to claim 1, wherein: The processor is configured to determine that the injection endpoint has been reached when: data and / or information received from the magnetometer, the data and / or information indicating a maximum resultant magnetic field strength; and Data and / or information is received from the accelerometer, the data and / or information indicating an absence of acceleration along the z-axis for a predetermined duration.
7. The injection endpoint monitoring system according to claim 1, wherein: The processor is configured to sample data and / or information received from the magnetometer and / or accelerometer at a frequency between about 20 Hz and about 400 Hz.
8. The injection endpoint monitoring system according to claim 1, wherein: The processor is configured to simultaneously and synchronously analyze the magnetogram of the data and / or information received from the magnetometer and the acceleration profile of the data and / or information received from the accelerometer to determine any predefined operational state of an injection procedure.
9. An injection monitoring module comprising the system according to any one of claims 1 to 10.
10. The injection monitoring module according to claim 11, wherein: The magnetic field generator is located on a first cylindrical body having a central longitudinal hole and a central longitudinal axis, the first cylindrical body being configured to rotate about the central longitudinal axis, and The processor, magnetometer, and accelerometer are located on a second body configured to translate within the central longitudinal bore of the first cylindrical body from a first proximal injection position to a second distal injection position.
11. A method for determining an injection endpoint, comprising: i. installing an injection monitoring module to the proximal end of the injection pen system, the injection monitoring module comprising an injection endpoint monitoring system according to any one of claims 1 to 10, the injection pen system comprising a proximal start button; ii. adjusting the dose on the injection pen system; iii. Start the proximal start button of the injection pen system; iv. configuring the processor of the injection endpoint monitoring system to process the data and / or information synchronously received from the magnetometer and accelerometer of the injection endpoint monitoring system to determine the endpoint of the injection operation of the injection pen injection system.
12. The method of claim 11 , comprising configuring a processor of the injection endpoint monitoring system to process data and / or information synchronously received from a magnetometer and an accelerometer of the injection endpoint monitoring system, wherein the data and / or information relates to one or more axes selected from an x-axis, a y-axis, a z-axis, or a combination of one or more of the axes.
13. The method according to claim 11, wherein: The processor is configured to process data and / or information received from the magnetometer and measured along the x-axis and y-axis, both of which are perpendicular to the z-axis.
14. The method according to claim 11, wherein: The processor is configured to determine that a dose has been set if: Data and / or information is received from the magnetometer, the data and / or information indicating that the resultant magnetic field strength has increased above a baseline value and below a predetermined maximum value.
15. The method according to claim 11, wherein: The processor is configured to determine that the injection endpoint has been reached when: receiving data and / or information from the magnetometer, the data and / or information indicating a maximum combined magnetic field strength; and Data and / or information is received from the accelerometer, the data and / or information indicating an absence of acceleration along the z-axis for a predetermined duration.
16. The method according to claim 11, wherein: The processor is configured to sample data and / or information received from the magnetometer and / or accelerometer at a frequency between about 20 Hz and about 400 Hz.
17. The method according to claim 11, wherein: The processor is configured to simultaneously and synchronously analyze a magnetogram curve of data and / or information received from the magnetometer and an acceleration curve of data and / or information received from the accelerometer to determine any predefined operating state of an injection procedure.
